Posts by Cystic Fibrosis Foundation - Wisconsin Chapter Milwaukee Office
The U.S. Food and Drug Administration (FDA) has set a target
The U.S. Food and Drug Administration (FDA) has set a target review date of July 5, 2015, for the combination therapy of lumacaftor and ivacaftor to t...
The U.S. Food and Drug Administration (FDA) has set a target review date of July 5, 2015, for the combination therapy of lumacaftor and ivacaftor to t...